Form Health Review: ABOM-Certified Obesity Medicine Telehealth (May 2026)

Most GLP-1 telehealth platforms in 2026 operate at the prescribing end of the clinical spectrum: asynchronous intake, a nurse practitioner or general-practitioner review, and a prescription dispatched. Form Health is built differently. Its care team is led by a physician certified by the American Board of Obesity Medicine — the obesity-medicine specialty board — and every patient is paired with a Registered Dietitian as a standard part of the program, not an add-on.

That clinical architecture comes at a price, and it is designed specifically around insurance. Cash-pay patients pay $299 per month before labs and medication. Insured patients pay $99 per month, with visits, labs, and drugs billed through their plan. For patients whose insurance covers GLP-1s, Form Health’s combination of specialist oversight and active prior-authorisation support is hard to match at this price point.

This review covers the clinical model, the real cost structure, how the LillyDirect and NovoCare partnerships affect your experience, and how Form Health compares to Calibrate — the other major insurance-first platform.

Form Health at a glance

This article carries an editorial-only reviewer status — clinical scoring awaits MD reviewer onboarding per our editorial policy.

What Form Health is

Form Health was founded in 2019 with a specific thesis: obesity is a chronic disease requiring specialist medicine, not a lifestyle failing requiring an app. Every patient’s care team is led by a physician who holds ABOM certification, paired with a Registered Dietitian who also holds the CSOWM (Certified Specialist in Obesity and Weight Management) credential from the Academy of Nutrition and Dietetics.

This is a genuine structural differentiator. Most telehealth GLP-1 platforms operate with general-practice clinicians or nurse practitioners who can legally prescribe but have not trained specifically in obesity medicine. An ABOM diplomate has cleared a specialty examination that general prescribers have not, and the credential indicates training in the chronic disease management model that the evidence base for GLP-1 medications is built around.

The company transitioned from direct-to-consumer to an insurance-in-network model as it scaled. It now operates as an in-network provider for most major commercial insurance plans and Medicare, treating the membership fee as the patient cost and routing clinical visits, labs, and medications through insurance billing — the same way a specialist clinic bills.

Pricing reality

Insured patients: $99/month

If Form Health is in-network with your insurer, the membership fee is $99 per month. Your clinical visits, lab work, and GLP-1 prescriptions are billed through insurance at standard copay and coinsurance rates — the same way an in-person specialist visit would be billed.

What this means in practice varies by plan. A patient on a generous employer-sponsored plan may pay $20–$30 per visit in copays, close to $0 for labs, and their GLP-1 copay through the plan’s pharmacy benefit. A patient with a high-deductible plan will pay more until their deductible is met. Form Health publishes its accepted insurance list and offers a coverage-verification step at intake.

As of May 2026, NovoCare pricing for branded Wegovy is $349/month flat (or $199/month for the two lowest starter doses). LillyDirect pricing for Zepbound starts at $299/month. If your insurance covers the drug, your actual cost after copay will typically be lower than those self-pay benchmarks.

Self-pay patients: $299/month minimum, plus medication

Without insurance, the membership is $299 per month. This covers ABOM physician visits, dietitian appointments, unlimited messaging, and app access. Labs are billed separately ($35–$150 depending on panel). Medications are an additional cost on top of membership.

At list price: branded Wegovy through NovoCare is $349/month; branded Zepbound through LillyDirect starts at $299/month. A realistic self-pay total for a Form Health patient on Zepbound is approximately $600–$750 per month depending on dose tier and lab frequency.

This is expensive. Form Health acknowledges it, and its own published guidance on cost frames insurance as the intended access path. For uninsured patients, the clinical quality argument is real — ABOM expertise is hard to replicate at lower price points — but the math is demanding.

HSA and FSA funds can be applied to the membership fee.

The ABOM credential: what it means for your experience

The American Board of Obesity Medicine was established in 2011. Earning the ABOM diplomate designation requires an active primary board certification (internal medicine, family medicine, endocrinology, or another ABMS member board), completion of at least 60 AMA Category 1 CME credits in obesity medicine within 36 months, and passage of a written examination. Physicians must maintain their certification through continuing education.

In practical terms, what does seeing an ABOM physician change compared to a general-practice telehealth prescriber?

Comorbidity awareness. Obesity interacts with type 2 diabetes, hypertension, sleep apnea, and cardiovascular disease in ways that affect both GLP-1 dosing and monitoring requirements. An ABOM-trained physician has specific training in these interactions; a general prescriber may not.

Dose titration discipline. GLP-1 medications have FDA-labelled titration schedules, but real-world tolerance varies. An obesity medicine specialist is trained in managing side effects through titration adjustments, temporary holds, and dietary modifications alongside the medication.

Long-term treatment framing. Obesity medicine trains physicians to treat obesity as a chronic disease requiring indefinite management, not a temporary intervention. This affects how Form Health’s clinicians discuss drug continuity, weight regain risk if medication is stopped, and long-term care planning — conversations that are often absent from platforms optimised for quick prescribing.

Medication selection. An ABOM clinician evaluates which anti-obesity medication (AOM) is appropriate for a specific patient based on their comorbidities, history, and response — including non-GLP-1 options like Contrave (naltrexone-bupropion) or Saxenda (liraglutide) when clinically indicated.

The Registered Dietitian co-assigned to each patient adds a complementary dimension. The dietitian works on eating behaviour, nutritional adequacy during the appetite-suppression phase, and maintenance planning for the period when medication is eventually reduced or stopped. The RD credential indicates licensure and a four-year degree in nutritional science; the CSOWM board certification is specific to obesity nutrition practice.

Insurance navigation and prior authorisation

Prior authorisation for GLP-1 medications is one of the most consistently friction-filled parts of the patient experience across all telehealth platforms. Most commercial insurance plans require documentation of qualifying BMI, the presence of weight-related comorbidities, and evidence that the patient is enrolled in a supervised weight management program before approving coverage for Wegovy or Zepbound.

Form Health’s clinical team handles PA submission as part of the membership. The process typically involves:

1. Confirming your plan’s coverage criteria at intake
2. Gathering the required clinical documentation (BMI, comorbidities, prior weight-loss history)
3. Submitting the PA request to your insurer
4. Following up with the insurer through the review period
5. Filing an appeal if the initial request is denied

Patient reviews consistently cite Form Health’s PA support as one of the program’s strongest practical benefits. The PA workload on the patient side is substantially reduced compared to trying to navigate the process through a primary care provider who may have limited experience with GLP-1 PA requirements.

A denial is not the end of the process. Common denial reasons include missing documentation of qualifying comorbidities, insufficient BMI documentation, or the plan requiring step therapy (trying a lower-cost medication first). Form Health’s team is experienced in identifying and addressing the specific basis for a denial and constructing the appeal accordingly.

For a detailed walkthrough of the PA process and what to do if your appeal fails, see GLP-1 prior authorisation appeals.

The LillyDirect and NovoCare partnerships

Form Health is one of three telehealth platforms that Eli Lilly lists on its LillyDirect platform as prescribing partners for Zepbound — the others are 9amHealth and Knownwell. It is also one of two platforms linked by Novo Nordisk’s NovoCare program for Wegovy access (alongside 9amHealth).

What being a pharmaceutical manufacturer’s telehealth partner means in practice is worth understanding clearly:

What it is: A referral arrangement. Patients who visit LillyDirect or NovoCare and indicate interest in telehealth-facilitated access are directed to Form Health (and other partner platforms) to be evaluated for prescription eligibility. The platforms provide a straightforward path from “I want Zepbound” to a physician who can prescribe it.

What it is not: An exclusivity arrangement or a financial incentive to prescribe. Eli Lilly has publicly stated that Form Health physicians are independent and are not compensated for prescribing Zepbound specifically. Form Health’s CEO has confirmed the company prescribes from all major manufacturers. In practice, approximately 66% of Form Health prescriptions in 2024 were for Lilly products — a number the company attributes to Zepbound’s clinical efficacy at weight-loss endpoints rather than manufacturer influence.

For patients, the main practical implication is that accessing Form Health through LillyDirect gives you a clear path to Zepbound specifically. For the LillyDirect self-pay vial program and current pricing details, see LillyDirect Zepbound enrollment. If your insurer covers Zepbound, Form Health’s PA support means the manufacturer’s retail program pricing is often not relevant to your actual cost.

There are legitimate questions in the policy sphere about whether pharmaceutical manufacturer’s telehealth partnerships risk narrowing patients’ medication options. A 2025 Senate probe found that similar arrangements at other platforms carried risks of unnecessary prescribing. Form Health’s ABOM-physician model and its record of prescribing across manufacturers provides more structural protection against that dynamic than lighter-credentialled platforms — but patients evaluating any LillyDirect-linked provider should understand the architecture.

Sign-up and intake

The Form Health intake begins with a three-minute qualification quiz covering height, weight, health history, and insurance information. Eligibility requires a BMI of 30 or higher, or 27 or higher with a weight-related health condition (such as hypertension, type 2 diabetes, or sleep apnea). Form Health also requires that you have seen a primary care provider within the past 12 months — a stipulation that reflects its clinical model rather than a regulatory requirement.

After the quiz, you provide insurance information for coverage verification, download the Form Health app, and schedule your initial video visits with both the clinician and the Registered Dietitian. Month one is the assessment period: the physician and dietitian each conduct an initial evaluation, develop a personalised treatment plan, and determine whether FDA-approved medication is clinically appropriate.

Prescription for a GLP-1 medication, if appropriate, typically follows the initial physician visit. If PA is required under your insurance plan, the PA process begins at this stage — timelines vary by insurer, typically one to four weeks for an initial decision.

Support quality

Form Health operates a dedicated weight-management clinical team, not a general telehealth on-call system. Your assigned physician and dietitian are the primary contacts throughout your time on the platform.

The standard structure includes monthly video visits with both your clinician and your dietitian, plus unlimited messaging between appointments through the Form Health app. Monthly group video classes are available for patients who want peer engagement. The app supports weight and food tracking.

Negative patient reviews on Trustpilot cite two consistent pain points: occasional difficulty scheduling appointments during periods of high demand, and the absence of a phone support line for billing and insurance questions. The patient experience for clinical matters — physician responsiveness, dietitian quality, medication management — receives consistently high marks. Operational frictions (insurance verification delays, billing questions) are the primary complaints from the minority of dissatisfied reviewers.

Cancellation

Form Health membership is month-to-month with no long-term commitment. You can cancel at any time. A 30-day money-back guarantee applies to first-time patients: if you are not satisfied within the first 30 days, a full refund is available on request.

On cancellation, the clinical team offers to help you create a transition plan. Your records are yours under HIPAA; Form Health will provide them to a subsequent provider on your request.

Best for / Not for

Form Health is best suited to:

• Insured patients whose commercial plan or Medicare may cover GLP-1s for weight management and who want a clinician experienced in PA navigation
• Patients who want an ABOM-certified specialist rather than a general-practice prescriber
• Patients who value a built-in Registered Dietitian as part of standard care, not an optional add-on
• Patients who want branded FDA-approved medications only and have no interest in compounded alternatives
• Medicare patients — Form Health’s Medicare acceptance is a differentiator in the telehealth space

Form Health is not ideal for:

• Patients without insurance and on a tight budget — $299/month plus medication is a high floor
• Patients whose insurance definitively does not cover GLP-1s and who want a cash-pay alternative with lower all-in cost
• Patients looking for compounded semaglutide or tirzepatide at below-branded pricing
• Patients who prefer a minimal-touchpoint asynchronous model — Form Health’s team-based structure requires engagement

Form Health vs Calibrate: the insurance-first platforms compared

Calibrate is the closest structural comparison to Form Health: both are insurance-first obesity medicine telehealth platforms oriented around branded GLP-1 medications, PA navigation, and long-term metabolic health management. The differences matter.

The most clinically significant difference is the behaviour-support model. Form Health pairs every patient with a licensed Registered Dietitian — a clinical credential that requires a four-year nutrition degree, a supervised internship, and a national examination. Calibrate’s behaviour support is delivered by coaches, who may or may not hold clinical credentials. For patients with complex nutritional requirements, specific dietary restrictions, or metabolic conditions that interact with eating patterns, the RD distinction is material.

Calibrate’s one-year commitment model also creates a structural difference in programme framing. Calibrate’s “metabolic reset” is designed as a defined intervention with a 10% weight-loss guarantee; Form Health is structured as ongoing specialist medical care without a set end date. Which framing is better depends on how you think about obesity as a condition.

Calibrate’s lower self-pay membership price ($149 vs $299) is meaningful for uninsured patients, and Calibrate’s availability of compounded medications gives it a cash-pay path that Form Health does not offer. Form Health wins on clinical credential depth and dietitian quality; Calibrate wins on programme structure and cash-pay medication options.

For a full comparison across all platforms, see GLP-1 provider comparison.

What patients say

Direct Reddit discussions specifically about Form Health are sparse relative to the platform’s size, which may reflect the more clinical, insured patient demographic the platform attracts. From aggregated review sources and the broader GLP-1 telehealth community:

On the physician quality: Patients who engage fully with the Form Health model report a noticeably different clinical interaction compared to asynchronous platforms — physicians who discuss mechanism, titration rationale, and comorbidity context rather than simply approving a dose escalation request. The ABOM credential appears to translate to a more substantive clinical conversation.

On prior authorisation: The PA support is the most commonly cited reason patients choose Form Health over cheaper alternatives. Patients who have navigated PA denials with Form Health’s team describe the process as significantly less burdensome than handling it through a primary care provider who has limited GLP-1 PA experience. The frustration that does appear in negative reviews comes from PA denials that Form Health cannot override — a function of the patient’s insurance plan excluding GLP-1s entirely, not a failure of Form Health’s advocacy.

On cost for uninsured patients: The $299 membership is a recurring friction point in reviews from patients who expected lower cost based on initial marketing. Combined with medication costs, the all-in figure for uninsured patients surprises those who discovered the structure only after enrolling. Form Health’s own FAQ notes that the programme works best when insurance is in place.

On the dietitian relationship: The pairing of physician and dietitian as a standard team — not an optional upgrade — is consistently mentioned in positive reviews as a differentiator. Patients describe dietitian appointments as substantive clinical interactions, not motivational check-ins.

How we keep this article current

We recheck this review on a regular cadence. Three areas move fastest and are where we update first:

• Pricing. Form Health’s $99 and $299 membership tiers are verified as of May 2026 through published sources. These may change with competitive pressure or partnership arrangements. Check formhealth.co directly before enrolling.
• The LillyDirect and NovoCare partnership footprint. Both manufacturer-linked telehealth programs have been expanding and adjusting their partner lists. If Form Health is added to or removed from either program, the access dynamics described here will change.
• Insurance coverage for GLP-1s. The Medicare GLP-1 Bridge effective July 1 2026 changes the Medicare access picture. Commercial insurance GLP-1 coverage is still inconsistent and evolving. Whether your specific plan covers Wegovy or Zepbound for weight management is the single most important variable in whether Form Health is cost-effective for you.

For the broader LillyDirect enrollment process and current Zepbound pricing, see LillyDirect Zepbound enrollment. For an appeals guide if your PA is denied, see GLP-1 prior authorisation appeals. To compare Form Health against the full provider landscape, see GLP-1 provider comparison. For a detailed review of Calibrate, see Calibrate review.

If you spot an error or a missing source, email [email protected]. Our editorial policy explains how we source and update provider reviews.